Spear Bio was founded to help researchers and clinicians advance the field of proteomics by delivering ultrasensitive immunoassays that fit into existing workflows for sample collection, processing and detection. Our technology enables use of sample sizes too small for existing methods to reliably detect. With this new capability Spear Bio can aid in biomarker discovery, early detection of disease,
and remote patient monitoring.